arrow
A

Akshay S. Desai

Brigham and Women's Hospital
H指数:101
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Rescue to Interception: The PREVENT 2-LATE (PReserve Eligibility Via Early, Necessary Transfer) Framework for Advanced Heart Failure

从救援到拦截:PREVENT 2-LATE(通过早期必要转移保留资格)框架用于治疗心力衰竭

2026-08-270
PRE
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益:FINE-HEART合并分析

2026-08-180
OAAI
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis

心力衰竭患者的最佳血清钾浓度:一项个体患者数据Meta分析

2026-05-280
PRE
Artificial Intelligence to Extract Structured Details From Unstructured Medical Records in a Global Heart Failure Trial

利用人工智能从全球心力衰竭试验中的非结构化医疗记录中提取结构化详细信息

2026-01-050
PRE
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial

非奈利酮、多药治疗和心力衰竭患者的临床结局:FINEARTS-HF试验的预先指定分析

2026-01-010
OA
Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR Insights from FINEARTS-HF

非奈利酮和eGFR斜率在不同基线白蛋白尿和eGFR水平下的差异:FINEARTS-HF研究启示

2025-11-010
PRE
Implementing HeartPal: Design and Early Results of a Specialized Care Delivery Model for Advancing Palliative Care in Advanced Heart Disease Populations

实施HeartPal:针对晚期心脏病人群推进姑息治疗的专业化照护模式设计与初步结果

2025-10-060
PRE
Lifetime Benefits of Comprehensive Medical Therapy in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

轻度或保留射血分数心力衰竭患者综合药物治疗的全生命周期获益

2025-10-060
PRE
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial

根据胰岛素抵抗在心力衰竭中的作用:FINEARTS-HF试验的见解

2025-09-080
OAAI
Effect of Finerenone on Morbidity and Mortality in CKD

非奈利酮对CKD患者发病率和死亡率的影响

2025-09-010
OA
Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

与肥胖度相关的体质测量指标及在轻度射血分数降低或保留的心力衰竭中的临床结局

JACC
IF0
2025-08-270
PRE
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

利钠肽、体重指数及轻度射血分数降低或保留的心力衰竭患者的临床结局

JACC
IF0
2025-08-270
PRE
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction

实现射血分数和达格列净在射血分数改善型心力衰竭中的效果

2025-08-190
OAAI
Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial

FINEARTS-HF试验中,长期治疗后Finerenone的盲法撤药

2025-07-280
OA